MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

Search

10X Genomics Inc (Class A)

Cerrado

SectorSanidad

12.65 4.72

Resumen

Variación precio

24h

Actual

Mínimo

12.08

Máximo

12.74

Métricas clave

By Trading Economics

Ingresos

15M

-34M

Ventas

-10M

155M

Margen de beneficios

-22.183

Empleados

1,306

EBITDA

-1.5M

-39M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+7.44% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

542M

1.6B

Apertura anterior

7.93

Cierre anterior

12.65

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

10X Genomics Inc (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 jul 2025, 21:42 UTC

Adquisiciones, fusiones, absorciones

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10 jul 2025, 17:06 UTC

Adquisiciones, fusiones, absorciones

Portugal Begins Process to Sell Stake in National Carrier -- Update

10 jul 2025, 17:00 UTC

Principales Movimientos del Mercado

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10 jul 2025, 16:31 UTC

Adquisiciones, fusiones, absorciones

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10 jul 2025, 23:47 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10 jul 2025, 23:40 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10 jul 2025, 22:36 UTC

Charlas de Mercado

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10 jul 2025, 22:23 UTC

Charlas de Mercado

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10 jul 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

10 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 jul 2025, 20:00 UTC

Adquisiciones, fusiones, absorciones

Toyota Tsusho America Completes Acquisition of Radius Recycling

10 jul 2025, 19:56 UTC

Charlas de Mercado

Gold Rises on Inflation Concerns -- Market Talk

10 jul 2025, 19:33 UTC

Charlas de Mercado

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10 jul 2025, 19:21 UTC

Charlas de Mercado

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10 jul 2025, 18:46 UTC

Charlas de Mercado

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10 jul 2025, 18:15 UTC

Charlas de Mercado

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10 jul 2025, 18:03 UTC

Charlas de Mercado
Ganancias

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10 jul 2025, 17:57 UTC

Charlas de Mercado

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10 jul 2025, 17:34 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10 jul 2025, 17:34 UTC

Charlas de Mercado

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10 jul 2025, 17:20 UTC

Charlas de Mercado

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10 jul 2025, 17:20 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

10 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 jul 2025, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

10 jul 2025, 16:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10 jul 2025, 16:01 UTC

Adquisiciones, fusiones, absorciones

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10 jul 2025, 15:41 UTC

Charlas de Mercado

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Comparación entre iguales

Cambio de precio

10X Genomics Inc (Class A) previsión

Precio Objetivo

By TipRanks

7.44% repunte

Estimación a 12 Meses

Media 13 USD  7.44%

Máximo 18 USD

Mínimo 9 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para 10X Genomics Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

4

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

8.32 / 8.63Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.